Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Medication 1 improved hair quality and growth more effectively than medication 2 and the placebo.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Combining PRP with a special lotion is more effective for hair loss than PRP alone.

TrichovitalsTM improved skin, hair, and nail health in adults after 12 weeks.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Topical booster improves hair loss treatment effectiveness.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.